Evofem Biosciences, Inc. Contracts & Agreements
199 Contracts & Agreements
- Business Finance (111 contracts)
- Business Operations (5)
- Human Resources (37)
- Intellectual Property (2)
- Mergers & Acquisitions (4)
- Real Estate (6)
- Uncategorized (34)
- Third Amendment to Agreement and Plan of Merger dated as of February 29, 2024, by and among Aditxt, Inc., Adicure, Inc. and Evofem Biosciences, Inc (Filed With SEC on March 6, 2024)
- Second Amendment to the Merger Agreement, dated January 30, 2024 (Filed With SEC on January 31, 2024)
- First Amendment to the Merger Agreement, dated January 8, 2024 (Filed With SEC on January 11, 2024)
- Form of Waiver and Rights Exchange Agreement (Filed With SEC on December 27, 2023)
- Form of Amendment and Preferred Exchange Agreement (Filed With SEC on December 27, 2023)
- Definitive Agreement by and between the Company and Aditxt, Inc (Filed With SEC on December 12, 2023)
- Form of Senior Subordinated Convertible Note (Filed With SEC on December 7, 2023)
- Form of Restructuring Agreement (Filed With SEC on December 7, 2023)
- Amended Employment Agreement, by and between the Registrant and Ivy Zhang, dated as of November 8, 2023 (Filed With SEC on November 14, 2023)
- Amended Employment Agreement, by and between the Registrant and Saundra Pelletier, dated as of November 8, 2023 (Filed With SEC on November 14, 2023)
- Form of Securities Purchase Agreement (Filed With SEC on October 3, 2023)
- Form of Senior Subordinated Convertible Note (Filed With SEC on October 3, 2023)
- Form of Warrant (Filed With SEC on October 3, 2023)
- Form of Registration Rights Agreement (Filed With SEC on October 3, 2023)
- Fourth Amendment to Securities Purchase and Security Agreement (Filed With SEC on September 11, 2023)
- Form of Securities Purchase Agreement (Filed With SEC on August 10, 2023)
- Form of Senior Subordinated Convertible Note (Filed With SEC on August 10, 2023)
- Form of Warrant (Filed With SEC on August 10, 2023)
- Form of Registration Rights Agreement (Filed With SEC on August 10, 2023)
- Form of Exchange Agreement (Filed With SEC on August 10, 2023)
- Form of Securities Purchase Agreement (Filed With SEC on July 10, 2023)
- Form of Senior Subordinated Convertible Note (Filed With SEC on July 10, 2023)
- Form of Warrant (Filed With SEC on July 10, 2023)
- Form of Registration Rights Agreement (Filed With SEC on July 10, 2023)
- Offer Letter, by and between the Registrant and Ivy Zhang, dated as of April 10, 2023 (Filed With SEC on June 16, 2023)
- Form of Securities Purchase Agreement (Filed With SEC on April 10, 2023)
- Form of Senior Subordinated Convertible Note (Filed With SEC on April 10, 2023)
- Form of Warrant (Filed With SEC on April 10, 2023)
- Form of Registration Rights Agreement (Filed With SEC on April 10, 2023)
- Form of Securities Purchase Agreement (Filed With SEC on March 24, 2023)
- Form of Senior Subordinated Convertible Note (Filed With SEC on March 24, 2023)
- Form of Warrant (Filed With SEC on March 24, 2023)
- Form of Registration Rights Agreement (Filed With SEC on March 24, 2023)
- Form of Securities Purchase Agreement (Filed With SEC on March 14, 2023)
- Form of Senior Subordinated Convertible Note (Filed With SEC on March 14, 2023)
- Form of Warrant (Filed With SEC on March 14, 2023)
- Form of Registration Rights Agreement (Filed With SEC on March 14, 2023)
- Form of Securities Purchase Agreement (Filed With SEC on February 23, 2023)
- Form of Senior Subordinated Convertible Note (Filed With SEC on February 23, 2023)
- Form of Warrant (Filed With SEC on February 23, 2023)
- Form of Registration Rights Agreement (Filed With SEC on February 23, 2023)
- Forbearance Agreement, dated as of September (Filed With SEC on September 16, 2022)
- Forbearance Agreement, dated as of September (Filed With SEC on September 16, 2022)
- Subordination Agreement, dated as of September 15, 2022, by and among Global Health Technology Fund, LP, Adjuvant Global Health Technology Fund, DE, LP, and certain institutional... (Filed With SEC on September 16, 2022)
- Form of Investor Exchange Agreement (Filed With SEC on September 16, 2022)
- Form of Adjuvant Exchange Agreement (Filed With SEC on September 16, 2022)
- Form of Right (Filed With SEC on September 16, 2022)
- Third Amendment to Securities Purchase and Security Agreement, dated as of September 15, 2022, by and among Evofem Biosciences, Inc., certain institutional investor and their... (Filed With SEC on September 16, 2022)
- Second Amendment to Securities Purchase Agreement, dated as of September 15, 2022, by and among Evofem Biosciences, Inc., Adjuvant Global Health Technology Fund, LP, and Adjuvant... (Filed With SEC on September 16, 2022)
- Office Sublease, dated as of May 27, 2022, by and between Evofem Biosciences, Inc. and AMN Healthcare, Inc (Filed With SEC on August 12, 2022)
- Underwriting Agreement, dated as of May 20, 2022, by and between Evofem Biosciences, Inc. and Piper Sandler & Co (Filed With SEC on May 23, 2022)
- Form of Pre-Funded Warrant To Purchase Common Stock (Filed With SEC on May 23, 2022)
- Form of Common Warrant To Purchase Common Stock (Filed With SEC on May 23, 2022)
- Form of Senior Subordinated Note (Filed With SEC on May 5, 2022)
- Form of Senior Subordinated Note (Filed With SEC on May 5, 2022)
- Form of Warrant (Filed With SEC on May 5, 2022)
- Form of Amendment and Exchange Agreement For Existing Notes (Filed With SEC on May 5, 2022)
- Form of Amendment and Exchange Agreement For Preferred Stock (Filed With SEC on May 5, 2022)
- Form of Amendment and Exchange Agreement For Equity Line Shares (Filed With SEC on May 5, 2022)
- First Amendment to Securities Purchase Agreement, dated as of October 14, 2020, by and among Evofem Biosciences, Inc., Adjuvant Global Health Technology Fund, LP, and Adjuvant... (Filed With SEC on April 7, 2022)
- Form of Exchange Agreement (Filed With SEC on March 24, 2022)
- Second Amendment to Securities Purchase and Security Agreement, dated as of April 23, 2020, by and among Evofem Biosciences, Inc., certain affiliates of Baker Bros. Advisors LP,... (Filed With SEC on March 21, 2022)
- Description of Evofems securities registered pursuant to Section 12(b) of the Securities Exchange Act of 1934 (Filed With SEC on March 10, 2022)
- Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on March 10, 2022)
- Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on March 10, 2022)
- Form of Warrant (Filed With SEC on March 1, 2022)
- Form of Senior Subordinated Note (Filed With SEC on March 1, 2022)
- Form of Securities Purchase Agreement (Filed With SEC on March 1, 2022)
- Purchase Agreement (Filed With SEC on February 16, 2022)
- Purchase Agreement (Filed With SEC on February 16, 2022)
- Form of Warrant (Filed With SEC on January 13, 2022)
- Form of Senior Subordinated Note (Filed With SEC on January 13, 2022)
- Securities Purchase Agreement (Filed With SEC on January 13, 2022)
- First Amendment to Securities Purchase and Security Agreement, dated as of April 23, 2020, by and among Evofem Biosciences, Inc., certain affiliates of Baker Bros. Advisors LP, as... (Filed With SEC on November 22, 2021)
- Confidential Employment Transition Plan and General Release Agreement, dated November 12, 2021 (Filed With SEC on November 15, 2021)
- Securities Purchase Agreement, dated October 11, 2021 (Filed With SEC on October 12, 2021)
- Underwriting Agreement, dated as of May 17, 2021, between Evofem Biosciences, Inc.and H.C. Wainwright & Co., LLC (Filed With SEC on May 19, 2021)
- Form of Warrant to Purchase Common Stock (Filed With SEC on May 19, 2021)
- Underwriting Agreement, dated as of March 24, 2021, among Evofem Biosciences, Inc., Morgan Stanley & Co. LLC and Stifel, Nicolaus & Company, Incorporated (Filed With SEC on March 25, 2021)
- Description of Evofems securities registered pursuant to Section 12(b) of the Securities Exchange Act of 1934 (Filed With SEC on March 4, 2021)
- Evofem Biosciences, Inc (Filed With SEC on March 4, 2021)
- Evofem Biosciences, Inc. Amended and Restated 2018 Inducement Equity Incentive Plan (Filed With SEC on March 4, 2021)
- Evofem Biosciences, Inc. Incentive Recoupment Policy (Filed With SEC on March 4, 2021)
- Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on March 4, 2021)
- Amendment No. 1 to Amended and Restated License Agreement, by and between Rush University Medical Center and Evofem, Inc., dated September 29, 2020 (Filed With SEC on November 9, 2020)
- Securities Purchase Agreement, dated as of October 14, 2020, by and between Evofem Biosciences, Inc., Adjuvant Global Health Technology Fund, L.P. and Adjuvant Global Health... (Filed With SEC on October 15, 2020)
- Form of Convertible Promissory Note (Filed With SEC on October 15, 2020)
- Registration Rights Agreement, dated as of October 14, 2020, by and between Evofem Biosciences, Inc., Adjuvant Global Health Technology Fund, L.P. and Adjuvant Global Health... (Filed With SEC on October 15, 2020)
- Letter Agreement, dated as of October 14, 2020, by and between Evofem Biosciences, Inc., Adjuvant Global Health Technology Fund, L.P. and Adjuvant Global Health Technology Fund... (Filed With SEC on October 15, 2020)
- Underwriting Agreement, dated as of June 2, 2020, among Evofem Biosciences, Inc., Morgan Stanley & Co. LLC and Piper Sandler & Co (Filed With SEC on June 3, 2020)
- Evofem Biosciences, Inc. Amended and Restated 2014 Equity Incentive Plan (Filed With SEC on May 12, 2020)
- First Amendment to Office Lease, dated as of April 14, 2020, by and between the Registrant and Kilroy Realty, L.P (Filed With SEC on May 6, 2020)
- Form of Warrant (Filed With SEC on April 27, 2020)
- Securities Purchase and Security Agreement, dated as of April 23, 2020, by and between Evofem Biosciences, Inc., its wholly-owned domestic subsidiaries as guarantors, certain... (Filed With SEC on April 27, 2020)
- Intellectual Property Security Agreement, dated as of April 23, 2020 by and between Evofem Biosciences, Inc., certain of its wholly-owned domestic subsidiaries and Baker Bros.... (Filed With SEC on April 27, 2020)
- Form of Note (Filed With SEC on April 27, 2020)
- Form of Registration Rights Agreement (Filed With SEC on April 27, 2020)
- Rights Agreement, dated as of March 24, 2020, by and between the Company and Philadelphia Stock Transfer, Inc., as rights agent (Filed With SEC on March 25, 2020)
- Description of Evofems securities registered pursuant to Section 12(b) of the Securities Exchange Act of 1934 (Filed With SEC on March 12, 2020)
- Supply and Manufacturing Agreement, dated November 4, 2019, by and between the Registrant and DPT Laboratories, Ltd (Filed With SEC on March 12, 2020)
- Evofem Biosciences, Inc. Amended and Restated 2014 Equity Incentive Plan (Filed With SEC on June 5, 2019)
- Evofem Biosciences, Inc. 2019 Employee Stock Purchase Plan (Filed With SEC on June 5, 2019)
- Consulting Agreement, dated as of April 1, 2019, by and between Evofem Biosciences Operations, Inc. and Thomas Lynch (Filed With SEC on May 7, 2019)
- Form of Warrant (Filed With SEC on April 11, 2019)
- Form of Warrant for Woodford (Filed With SEC on April 11, 2019)
- Securities Purchase Agreement (Filed With SEC on April 11, 2019)
- Registration Rights Agreement (Filed With SEC on April 11, 2019)
- Form of Reload Warrant (Filed With SEC on February 11, 2019)
- Form of Reload Warrant (Filed With SEC on February 11, 2019)
- Form of Repricing Letter Agreement (Filed With SEC on February 11, 2019)
- Form of Repricing Letter Agreement (Filed With SEC on February 11, 2019)
- 2018 Inducement Equity Incentive Plan (Filed With SEC on August 2, 2018)
- Notice of Grant of Stock Option under the 2018 Inducement Equity Incentive Plan (Filed With SEC on August 2, 2018)
- Executive Employment Agreement by and between the Company and Saundra Pelletier (Filed With SEC on July 3, 2018)
- Executive Employment Agreement by and between the Company and Justin J. File (Filed With SEC on July 3, 2018)
- Executive Employment Agreement by and between the Company and Kelly Culwell, M.D (Filed With SEC on July 3, 2018)
- Executive Employment Agreement by and between the Company and Russell Barrans (Filed With SEC on July 3, 2018)
- Executive Employment Agreement by and between the Company and Alexander A. Fitzpatrick, Esq (Filed With SEC on July 3, 2018)
- Form of Underwriting Agreement (Filed With SEC on May 16, 2018)
- Form of Common Warrant (Filed With SEC on May 16, 2018)
- Form of Pre-Funded Warrant (Filed With SEC on May 16, 2018)
- Evofem Biosciences, Inc. Amended and Restated 2014 Equity Incentive Plan (Filed With SEC on May 8, 2018)
- Form of Underwriting Agreement (Filed With SEC on April 24, 2018)
- Amended and Restated 2014 Equity Incentive Plan (Filed With SEC on April 6, 2018)
- Form of Stock Certificate (Filed With SEC on February 26, 2018)
- Letter Terminating Registrants Fourth Amended and Restated Investors Rights Agreement, dated January 17, 2018, by and between the Registrant and the investors listed therein (Filed With SEC on February 26, 2018)
- Separation and Release Agreement, dated January 29, 2018, by and between the Registrant and Maria Feldman (Filed With SEC on February 26, 2018)
- Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on February 26, 2018)
- Separation and Release Agreement, dated January 17, 2018, by and between the Registrant and Susan Knudson (Filed With SEC on January 17, 2018)
- Twelfth Amendment, dated as of December 4, 2017, by and between Neothetics, Inc. and LJ Gateway Office LLC (Filed With SEC on December 8, 2017)
- Form of Amended and Restated Warrant to Purchase Common Stock of Neothetics (Filed With SEC on November 15, 2017)
- Form of Warrant, by and between the Registrant and Invesco Asset Management Limited (Filed With SEC on November 15, 2017)
- Form of Voting Agreement (Filed With SEC on November 15, 2017)
- Stockholder Agreement, dated as of November 25, 2015, by and among Evofem Biosciences, Inc. and the stockholders of Evofem Biosciences, Inc. listed therein (Filed With SEC on November 15, 2017)
- First Amendment to Stockholder Agreement, dated as of July 13, 2016, by and among Evofem Biosciences, Inc. and the stockholders of Evofem Biosciences, Inc. listed therein (Filed With SEC on November 15, 2017)
- Second Amendment to Stockholder Agreement, dated as of July 28, 2017, by and among Evofem Biosciences, Inc. and the stockholders of Evofem Biosciences, Inc. listed therein (Filed With SEC on November 15, 2017)
- Registration Rights Agreement, dated as of November 25, 2015, by and among Evofem Biosciences, Inc. and the stockholders of Evofem Biosciences, Inc. listed therein (Filed With SEC on November 15, 2017)
- Consulting Agreement, dated as of April 1, 2017, by and between Evofem Biosciences, Inc. and Thomas Lynch (Filed With SEC on November 15, 2017)
- Severance Agreement, dated as of November 16, 2015, by and between Evofem Biosciences, Inc. and Justin J. File (Filed With SEC on November 15, 2017)
- Severance Agreement, dated as of April 27, 2015, by and between Evofem Biosciences, Inc. and Saundra Pelletier (Filed With SEC on November 15, 2017)
- Offer Letter, dated as of April 15, 2015, by and between Evofem Biosciences, Inc. and Kelly Culwell, M.D (Filed With SEC on November 15, 2017)
- Offer Letter, dated as of October 16, 2014, by and between Evofem Biosciences, Inc. and Saundra Pelletier (Filed With SEC on November 15, 2017)
- Offer Letter, dated as of March 8, 2015, as amended, by and between Evofem Biosciences, Inc. and Justin J. File (Filed With SEC on November 15, 2017)
- Amended Offer Letter, dated as of November 16, 2015, by and between the Evofem Biosciences, Inc. and Justin J. File (Filed With SEC on November 15, 2017)
- Form of Indemnification Agreement by and between Evofem Biosciences, Inc. and its officers and directors (Filed With SEC on November 15, 2017)
- Evofem Biosciences, Inc. Amended and Restated 2012 Equity Incentive Plan (Filed With SEC on November 15, 2017)
- Form of Notice of Option Grant and Option Agreement under the Evofem Biosciences, Inc. 2012 Equity Incentive Plan (Filed With SEC on November 15, 2017)
- Form of Grant of Restricted Stock Award under the Evofem Biosciences, Inc. 2012 Equity Incentive Plan (Filed With SEC on November 15, 2017)
- Amended and Restated License Agreement, by and between Rush University Medical Center and Evofem Biosciences, Inc., dated March 27, 2014 (Filed With SEC on November 15, 2017)
- Side Letter, dated as of October 11, 2017, by and between Evofem Biosciences, Inc. and Woodford Investment Management Limited (Filed With SEC on November 15, 2017)
- Consent to Sub-Sublease, dated as of January 30, 2015, by and among Evofem Biosciences, Inc., Kilroy Realty, L.P., Relational Investors LLC and WomanCare Global Trading, Inc (Filed With SEC on November 15, 2017)
- Sublease Guaranty, dated as of January 30, 2015, by and between Evofem Biosciences, Inc. and Relational Investors LLC (Filed With SEC on November 15, 2017)
- Agreement and Plan of Merger and Reorganization, dated October 17, 2017, by and among Neothetics, Inc., Evofem Biosciences, Inc. and Nobelli Merger Sub, Inc (Filed With SEC on October 17, 2017)
- Form of Support Agreement, by and between Evofem Biosciences, Inc. and certain of its stockholders (Filed With SEC on October 17, 2017)
- Form of Lock-Up Agreement (Filed With SEC on October 17, 2017)
- Securities Purchase Agreement, dated October 17, 2017, by and among the Company, Evofem Biosciences, Inc. and the investors listed therein (Filed With SEC on October 17, 2017)
- ELEVENTH AMENDMENT (Filed With SEC on February 14, 2017)
- SUBLEASE (Filed With SEC on February 14, 2017)
- NEOTHETICS, INC. AMENDMENT TO 2014 EQUITY INCENTIVE PLAN (Filed With SEC on August 11, 2016)
- WARRANT MODIFICATION AGREEMENT (Filed With SEC on May 12, 2016)
- SECOND AMENDMENT (Filed With SEC on May 12, 2016)
- SECOND AMENDMENT (Filed With SEC on April 1, 2016)
- WARRANT MODIFICATION AGREEMENT (Filed With SEC on April 1, 2016)
- CONFIDENTIAL SEPARATION AGREEMENT AND GENERAL RELEASE OF ALL CLAIMS (Filed With SEC on March 29, 2016)
- CONFIDENTIAL SEPARATION AGREEMENT AND GENERAL RELEASE OF ALL CLAIMS (Filed With SEC on March 29, 2016)
- Lease Amendment (9171 Towne Center Drive, Suite 270) BETWEEN LJ Gateway Office, LLC, a Delaware limited liability company AS LANDLORD AND Neothetics,Inc., a Delaware corporation... (Filed With SEC on March 26, 2015)
- [] Shares Neothetics, Inc. Common Stock PURCHASEAGREEMENT (Filed With SEC on November 10, 2014)
- Additional abbreviations may also be used though not in the above list. (Filed With SEC on November 10, 2014)
- FIRST AMENDMENT (Filed With SEC on November 10, 2014)
- NEOTHETICS, INC. AMENDED AND RESTATED 2007 STOCK PLAN (Filed With SEC on November 10, 2014)
- NEOTHETICS, INC. 2014EQUITY INCENTIVE PLAN (Filed With SEC on November 10, 2014)
- NEOTHETICS, INC. STOCKOPTION AGREEMENT (Filed With SEC on November 10, 2014)
- NEOTHETICS, INC. RESTRICTED STOCK UNITS AGREEMENT (Filed With SEC on November 10, 2014)
- NEOTHETICS, INC. RESTRICTED STOCK AGREEMENT (Filed With SEC on November 10, 2014)
- NEOTHETICS, INC. NOTICEOF GRANT OF RESTRICTED STOCK UNITS (Filed With SEC on November 10, 2014)
- NEOTHETICS, INC. NOTICEOF GRANT OF RESTRICTED STOCK (Filed With SEC on November 10, 2014)
- NEOTHETICS, INC. NOTICEOF GRANT OF STOCK OPTION (Filed With SEC on November 10, 2014)
- Neothetics, Inc. 2014EMPLOYEE STOCK PURCHASE PLAN Neothetics, Inc. 2014 Employee Stock Purchase Plan (Filed With SEC on November 10, 2014)
- WARRANT TO PURCHASE STOCK (Filed With SEC on October 17, 2014)
- WARRANT TO PURCHASE STOCK (Filed With SEC on October 17, 2014)
- WARRANT TO PURCHASE STOCK (Filed With SEC on October 17, 2014)
- WARRANTAGREEMENT To Purchase Shares of Preferred Stock of LITHERA, INC. Dated as ofJune 11, 2014 (the Effective Date) (Filed With SEC on October 17, 2014)
- NEOTHETICS, INC. FOURTH AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT September 22, 2014 TABLE OF CONTENTS (Filed With SEC on October 17, 2014)
- DECEMBER 12, 2012 TECHNOLOGY TRANSFER AGREEMENT By and Between DOMAIN RUSSIAINVESTMENTS LIMITED And LITHERA, INC. (Filed With SEC on October 17, 2014)
- ASSIGNMENT AND ASSUMPTION AGREEMENT (Filed With SEC on October 17, 2014)
- CLINICAL DEVELOPMENT AND COLLABORATION AGREEMENT (Filed With SEC on October 17, 2014)
- CONTRACT NO. 0702/12 (Filed With SEC on October 17, 2014)
- OFFICE SPACE LEASE BETWEEN WW&LJGATEWAYS, LTD. AND LIPOTHERA, INC. OFFICE SPACE LEASE (Filed With SEC on October 17, 2014)
- NINTH AMENDMENT (Filed With SEC on October 17, 2014)
- LOAN AND SECURITY AGREEMENT (Filed With SEC on October 17, 2014)
- EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on October 17, 2014)
- EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on October 17, 2014)
- EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on October 17, 2014)
- LITHERA, INC. 9191 Towne CentreDrive San Diego, CA 92122 July 3, 2014 (Filed With SEC on October 17, 2014)
- LITHERA, INC. 9191 Towne CentreDrive San Diego, CA 92122 August 12, 2014 (Filed With SEC on October 17, 2014)
- INDEMNIFICATION AGREEMENT (Filed With SEC on October 17, 2014)
- NEOTHETICS, INC. AMENDED AND RESTATED 2007 STOCK PLAN (Filed With SEC on October 17, 2014)
- NEOTHETICS, INC. 2007STOCK PLAN STOCK OPTION AGREEMENT (Filed With SEC on October 17, 2014)
- Non-Employee Director Compensation Policy (Filed With SEC on October 17, 2014)